Home › Funds › Aisling Capital Management LP › VTVT
Aisling Capital Management LP position in VTVT
VTV THERAPEUTICS INC · Health Care
Aisling Capital Management LP reported holding 58,775 shares of VTVT (VTV THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$1.8M, representing 0.61% of its reported portfolio and ranking #12 among its reported holdings. Aisling Capital Management LP has disclosed VTVT holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Aisling Capital Management LP's VTVT position evolved
Aisling Capital Management LP first disclosed a stake in VTVT in Q2 2026 at 50,000 shares (US$1.9M). Across 2 filings, Aisling Capital Management LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 58,775 shares valued at US$1.8M — an increase of 8,775 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 50.00K | $1.88M | New |
| Q3 2026 | 58.77K | $1.81M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VTVT and 13F data
VTVT (VTV THERAPEUTICS INC) is a Health Care company. 38 other funds we track also report a position in VTVT — the largest reported positions include Samsara BioCapital, LLC (US$11.2M), Trails Edge Capital Partners, LP (US$3.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VTVT
- Samsara BioCapital, LLC 298.50K sh · $11.24M · Q2 2026
- Trails Edge Capital Partners, LP 85.19K sh · $3.21M · Q2 2026
More on Aisling Capital Management LP
FAQ
How long has Aisling Capital Management LP held VTVT?
Aisling Capital Management LP has disclosed VTVT holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Aisling Capital Management LP's current position in VTVT?
As of Q3 2026, Aisling Capital Management LP holds 58.77K shares of VTVT (VTV THERAPEUTICS INC), valued at $1.81M, representing 0.61% of its reported portfolio and ranking #12.
Has Aisling Capital Management LP been buying or selling VTVT?
In the latest 13F filing (Q3 2026), Aisling Capital Management LP increased its position in VTVT.
Which other funds hold VTVT?
Other major institutional holders of VTVT include Samsara BioCapital, LLC, Trails Edge Capital Partners, LP, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.